Clinical trial Recruiting at 1 site Interventional

Wearable tools to support dementia care in rural Taiwan

Official title: Facilitating the Measurement and Treatment of the Behavioral Symptoms of Dementia (BPSD) and Understanding Caregiver Burden Using Wearable Devices in Rural Taiwan - A Dyadic Feasibility Pilot Study

Run by China Medical University Hospital · NCT07249918 · Data updated 2026-11-12

This project will test whether a wrist activity tracker and light-therapy glasses are easy to use and can help people with Alzheimer's dementia and their family caregivers in rural Taiwan.

More Circadian Rhythm trials

Quick facts

Study typeInterventional
SexAll
Enrollment20 (estimated)
SponsorChina Medical University Hospital
Academic / other
Locations1 site (Beigang, Yunlin)
StatusRecruiting
StartedNovember 18, 2025
Main results expectedSeptember 30, 2026
Study endsDecember 31, 2026
Registry record updatedFebruary 11, 2026
Trial IDNCT07249918 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with probable Alzheimer's disease or MCI due to AD who have at least one prominent behavioral or psychological symptom (such as agitation, apathy, depression, or nighttime sleep disturbance), a stable living situation, and the ability to consent or a legally authorized representative to consent.

Probably not a fit

People without prominent BPSD, with unstable living arrangements, with severe visual or wrist impairment that prevents wearing the devices, or who cannot tolerate the devices are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will give people with probable Alzheimer's disease (and their caregivers when appropriate) a GeneActiv wrist activity tracker to record continuous activity and sleep and Re-Timer light-therapy glasses to use for morning light exposure. The team will measure how willing participants are to wear the devices, how easy the devices are to use, and whether light therapy changes sleep patterns or caregiver stress over several weeks. Device-collected measures (for example sleep regularity) will be compared with standard caregiver questionnaires to see how well continuous data match reported symptoms. Findings will be used to plan larger studies and to explore whether wearable tools can be integrated into dementia care in aging rural communities.

Why it matters

Potential benefit: If successful, these wearables could provide continuous, objective sleep and activity data and offer a non-drug option (light therapy) to help improve sleep and reduce caregiver burden.

How similar studies have gone: Previous work has shown good compliance with research-grade actigraphy like GeneActiv even in late-stage AD, while light-therapy approaches have mixed but promising evidence for improving sleep and mood.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* For participants with dementia:

  1. Clinical diagnosis of probable Alzheimer's disease (AD) or mild cognitive impairment (MCI) due to AD, based on established diagnostic criteria.
  2. Presence of at least one prominent behavioral or psychological symptom of dementia (BPSD), including depression, agitation, apathy, or nighttime sleep disturbance.
  3. Prominent is defined as:

     NPI single-item score ≥ 4 (severity × frequency), or NPI-Q severity score ≥ 2, or PSQI total score ≥ 5 (if sleep disturbance is the main symptom).
  4. Stable living arrangement or care environment for at least two weeks before enrollment.
  5. If receiving any pharmacological or non-pharmacological treatments for BPSD, the dosage and frequency must have remained stable for at least two weeks prior to study participation.
  6. Able and willing to provide informed consent; for those lacking decision-making capacity, consent must be obtained from a legally authorized representative.
* For primary caregivers:

  1. Adult primary caregiver of the enrolled participant.
  2. If receiving treatment for caregiver stress, the dosage and frequency must have been stable for at least two weeks before enrollment.
  3. Willing and able to provide informed consent.

Exclusion Criteria:

* Any medical condition that may increase risk during participation, including:

  1. Retinal disease, active use of photosensitizing medications, recent ocular surgery (within 4 weeks), or photosensitivity disorders (e.g., epilepsy).
  2. Unstable physical or mental condition deemed unsuitable by investigators, such as acute delirium or active respiratory infection (including COVID-19)

Where it's running

  • China Medical University Beigang Hospital
    Beigang, Yunlin, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.